Power Solutions International designs and manufactures advanced engines and power systems for industrial and transportation markets.Gagnon Securities fully exited its position in Power Solutions International (PSIX +6.63%), selling approximately 64,770 shares in the fourth quarter. The estimated trade value was $6.36 million, according to a February 12, 2026, SEC filing.What happenedAccording to a SEC filing dated February 12, 2026, Gagnon Securities LLC sold its remaining 64,770 shares of Power Solutions I ...

Company Overview - Arcutis Biotherapeutics specializes in developing topical therapies for chronic skin conditions, focusing on psoriasis and atopic dermatitis [1][5] - The company generates revenue through proprietary dermatology treatments, primarily targeting prescription-based therapies for chronic inflammatory skin disorders [8] Recent Developments - Tejara Capital sold its entire holding of 520,503 shares in Arcutis Biotherapeutics, resulting in a decrease of $9.81 million in value [2][3] - This sale reduced Tejara Capital's position in Arcutis from 5.1% of assets under management (AUM) to zero [3] Financial Performance - As of February 4, shares of Arcutis Biotherapeutics were priced at $26.08, reflecting a 99.1% increase over the past year, significantly outperforming the S&P 500's 14% gain [3] - The company reported net product revenue of $99.2 million in the third quarter, more than doubling year over year, with management projecting full-year 2026 net product sales of approximately $455 million to $470 million [9] Market Position - Arcutis Biotherapeutics has transitioned into a revenue-scale phase, where sustained prescription growth and operational efficiency are critical for future returns [10] - The company’s lead products include roflumilast cream for plaque psoriasis and atopic dermatitis, with a focus on expanding its market presence [8]

Company Overview - Autoliv, Inc. is a leading supplier of automotive safety systems with a global footprint and a diversified customer base among major car manufacturers [6] - The company generates revenue through the sale of safety system modules and components to automotive manufacturers worldwide, focusing on both OEM supply contracts and ongoing product innovation [8] - Autoliv's revenue for the trailing twelve months (TTM) is $10.81 billion, with a net income of $735 million and a dividend yield of 2.59% [4] Recent Developments - On February 2, Tweedy, Browne Co disclosed the sale of 31,740 shares of Autoliv, valued at approximately $3.79 million, reducing their stake to 400,924 shares [2][3] - The value of Tweedy, Browne's position in Autoliv decreased by $5.84 million due to the sale and market movements over the quarter [2] - Autoliv's shares were priced at $120.49 as of February 2, reflecting a 32% increase over the past year, outperforming the S&P 500 by 12.78 percentage points [3] Financial Performance - In the most recent quarterly release, Autoliv reported $2.82 billion in revenue, representing a 7.7% year-over-year increase, with operating cash flow reaching a record $544 million [10] - Full-year operating cash flow totaled $1.16 billion, supporting dividends, buybacks, and maintaining a leverage ratio well below management's 1.5x ceiling [10] Future Outlook - Management is guiding for roughly flat organic growth in 2026, with an adjusted operating margin expected to be between 10.5% and 11.0% [11] - A weaker first quarter is anticipated, with expectations for improvement later in the year, indicating a solid but not explosive growth outlook [11] Investment Perspective - Autoliv remains a meaningful position in Tweedy Browne's portfolio, representing nearly 4% of assets, alongside other high-conviction holdings [12] - The recent share price increase suggests a disciplined approach to risk management, as even strong companies may warrant partial profit-taking after significant gains [9][12]